NCT05161039View on ClinicalTrials.gov

Serranator Recoil Study

NAUnknownINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

November 15, 2021

Primary Completion Date

July 31, 2022

Study Completion Date

July 31, 2022

Conditions
Peripheral Arterial DiseaseCritical Limb Ischemia
Interventions
DEVICE

Serranator

Serranator® PTA Serration Balloon Catheter manufactured by Cagent Vascular

DEVICE

POBA

Plain balloon angioplasty device

Trial Locations (2)

94305

RECRUITING

Stanford University, Palo Alto

Unknown

RECRUITING

Klinik für Angiologie, Klinikum Hochsauerland GmbH, Arnsberg

Sponsors
All Listed Sponsors
lead

Cagent Vascular LLC

INDUSTRY

NCT05161039 - Serranator Recoil Study | Biotech Hunter | Biotech Hunter